Oncotelic teams with TechForce Robotics to co-develop lab, pharma automation systems

ONCOTELIC THERAPEUTICS INC

ONCOTELIC THERAPEUTICS INC

OTLC

0.00
  • TechForce Robotics deployed its LIM-E autonomous lab support robot at Oncotelic Therapeutics under a joint development agreement.
  • Deployment completed Phase 1 objectives set in an April 2026 collaboration to evaluate robotics for GMP-regulated lab workflows.
  • Parties plan to assess additional automation opportunities, with a focus on lab logistics, manufacturing support, AI-driven workflow improvements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief on June 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.